Cargando…

Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study

Objective  This clinical study evaluated the clinical performance of composite resin inlays and onlays over 9 years. Materials and Methods  Sixty composite resin inlays and onlays were placed in 32 patients, aged 20 to 60 years, by a single operator using the same clinical procedure. The restoration...

Descripción completa

Detalles Bibliográficos
Autores principales: Galiatsatos, Aristidis, Galiatsatos, Panagiotis, Bergou, Dimitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890907/
https://www.ncbi.nlm.nih.gov/pubmed/34749421
http://dx.doi.org/10.1055/s-0041-1735420
_version_ 1784661750944104448
author Galiatsatos, Aristidis
Galiatsatos, Panagiotis
Bergou, Dimitra
author_facet Galiatsatos, Aristidis
Galiatsatos, Panagiotis
Bergou, Dimitra
author_sort Galiatsatos, Aristidis
collection PubMed
description Objective  This clinical study evaluated the clinical performance of composite resin inlays and onlays over 9 years. Materials and Methods  Sixty composite resin inlays and onlays were placed in 32 patients, aged 20 to 60 years, by a single operator using the same clinical procedure. The restorations were examined for fracture rate; esthetics; and patient acceptance and marginal integrity, including caries, marginal discoloration, tooth integrity, and surface texture. All restorations were evaluated at the time of placement and 3, 6, and 9 years after placement by using the modified U.S. Public Health Service criteria. Results  At the 3-year follow-up, an Alpha score was given to 88.4% of restorations, while a Bravo score was given to the remaining 11.6%. There was not any failure. At the 6-year follow-up, the success rate of the restorations was 100% without failure. None of the restorations was scored with Delta (D). An Alpha score was given to 60% of the restorations, a Bravo score was assigned to 35%, and a Charlie score was 5% of the restorations. Overall, the success rate of the restorations at 9-year follow-up was 85% and the failure rate was 15%. An Alpha score was given to 15% of the restorations, a Bravo score was given to 50%, a Charlie score was assigned to 20%, and a D score was given to 15% of the restorations. Conclusion  Indirect resin composite inlays and onlays showed acceptable long-term clinical results. The success rate of the restorations at 9-year follow-up was 85% and the failure rate was 15%.
format Online
Article
Text
id pubmed-8890907
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Medical and Scientific Publishers Private Ltd
record_format MEDLINE/PubMed
spelling pubmed-88909072022-03-03 Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study Galiatsatos, Aristidis Galiatsatos, Panagiotis Bergou, Dimitra Eur J Dent Objective  This clinical study evaluated the clinical performance of composite resin inlays and onlays over 9 years. Materials and Methods  Sixty composite resin inlays and onlays were placed in 32 patients, aged 20 to 60 years, by a single operator using the same clinical procedure. The restorations were examined for fracture rate; esthetics; and patient acceptance and marginal integrity, including caries, marginal discoloration, tooth integrity, and surface texture. All restorations were evaluated at the time of placement and 3, 6, and 9 years after placement by using the modified U.S. Public Health Service criteria. Results  At the 3-year follow-up, an Alpha score was given to 88.4% of restorations, while a Bravo score was given to the remaining 11.6%. There was not any failure. At the 6-year follow-up, the success rate of the restorations was 100% without failure. None of the restorations was scored with Delta (D). An Alpha score was given to 60% of the restorations, a Bravo score was assigned to 35%, and a Charlie score was 5% of the restorations. Overall, the success rate of the restorations at 9-year follow-up was 85% and the failure rate was 15%. An Alpha score was given to 15% of the restorations, a Bravo score was given to 50%, a Charlie score was assigned to 20%, and a D score was given to 15% of the restorations. Conclusion  Indirect resin composite inlays and onlays showed acceptable long-term clinical results. The success rate of the restorations at 9-year follow-up was 85% and the failure rate was 15%. Thieme Medical and Scientific Publishers Private Ltd 2021-11-08 /pmc/articles/PMC8890907/ /pubmed/34749421 http://dx.doi.org/10.1055/s-0041-1735420 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Galiatsatos, Aristidis
Galiatsatos, Panagiotis
Bergou, Dimitra
Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study
title Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study
title_full Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study
title_fullStr Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study
title_full_unstemmed Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study
title_short Clinical Longevity of Indirect Composite Resin Inlays and Onlays: An Up to 9-Year Prospective Study
title_sort clinical longevity of indirect composite resin inlays and onlays: an up to 9-year prospective study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890907/
https://www.ncbi.nlm.nih.gov/pubmed/34749421
http://dx.doi.org/10.1055/s-0041-1735420
work_keys_str_mv AT galiatsatosaristidis clinicallongevityofindirectcompositeresininlaysandonlaysanupto9yearprospectivestudy
AT galiatsatospanagiotis clinicallongevityofindirectcompositeresininlaysandonlaysanupto9yearprospectivestudy
AT bergoudimitra clinicallongevityofindirectcompositeresininlaysandonlaysanupto9yearprospectivestudy